Preview

Meditsinskiy sovet = Medical Council

Advanced search

Latent tuberculosis infection in risk groups of the adult population of the Saratov Region

https://doi.org/10.21518/ms2023-054

Abstract

Introduction. The priority of anti-tuberculosis work in the Saratov Region is the early detection of the disease and the prevention of new cases of pathology. The presence of medical and social risk factors for developing tuberculosis significantly increases the risk of developing local forms of tuberculosis, especially if patients have latent tuberculosis infection (LTBI).

Aim. To assess the prevalence of LTBI in the adult population with an increased risk of developing tuberculosis in the adult population.

Materials and methods. The design of the study is a retrospective non-comparative. The data of patients from high-risk groups for the development of the disease for the period of 2015–2019, examined using a skin test with a recombinant tuberculosis allergen (Diaskintest, Generium JSC, Russia) in the Saratov Region, were analyzed.

Results. 153,120 people from medical outpatient risk groups and 3,099 people from social risk groups were examined. Among adults with medical risk factors for developing tuberculosis, the largest number of positive and doubtful results of Diaskintest were recorded in patients with chronic bronchopulmonary pathology – 15.88%; among the group of those surveyed with social risk factors for developing tuberculosis – in persons released from penitentiary institutions (25.88%).

Conclusions. The decrease in incidence rates in the Saratov Region confirms the correctness of the chosen tactics regarding the use of the Diaskintest test to identify individuals with LTBI among the adult population and the implementation of measures to reduce the reservoir of tuberculosis infection. Given the effectiveness of the measures taken, it is advisable to work with risk groups for Diaskintest and further examination in a general medical network. To do this, it is necessary to make additions to the current Order of the Ministry of Health of the Russian Federation dated March 21, 2017 No. 124n “On approval of the procedure and terms for conducting preventive medical examinations of citizens in order to detect tuberculosis” regarding the use of recombinant tuberculosis allergen samples in the adult population.

About the Authors

T. I. Morozova
Razumovsky Saratov State Medical University; Saratov Regional Clinical Tuberculosis Dispensary
Russian Federation

Tatyana I. Morozova - Dr. Sci. (Med.), Professor, Head of the Department of Phthisiology, Razumovsky Saratov State Medical University; Chief Physician, Saratov Regional Clinical Tuberculosis Dispensary.

112, Bolshaya Kazachya St., Saratov, 410012; 22, Volskaya St., Saratov, 410056



N. P. Doktorova
National Medical Research Center for Phthisiopulmonology and Infectious Diseases
Russian Federation

Natalia P. Doktorova - Cand. Sci. (Med.), Researcher, Scientific Department of Differential Diagnosis and Treatment of Tuberculosis and Combined Infections, National Medical Research Center for Phthisiopulmonology and Infectious Diseases.

4, Bldg. 2, Dostoevsky St., Moscow, 127473



References

1. Nechayeva O.B., Son I.M., Eismont N.V. The prospects and capabilities of anti-tuberculosis service in the Russian Federation: discussion. Social Aspects of Population Health. 2012;(1). (In Russ.) Available at: http://vestnik.mednet.ru/content/view/391/30/lang,ru/.

2. Danilov A.N., Morozova T.I., Doktorova N.P. Dynamics of the main epidemic indicators of tuberculosis in the Saratov region. Saratov Journal of Medical Scientific Research. 2014;10(2):289–293. (In Russ.) Available at: https://ssmj.ru/system/files/2014_02_289-293.pdf.

3. Vasilyeva I.A., Sterlikov S.A., Testov V.V., Mikhailova Yu.V., Golubev N.A., Kucheryavaya D.A. et al. Resources and activities of TB organizations of the Russian Federation in 2020–2021 (statistical materials). Moscow: National Medical Research Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health; 2022. 92 p. (In Russ.)

4. Bogorodskaya E.M., Slogotskaya L.V., Belilovsky E.M., Roshchupkina O.M. Latent tuberculosis infection in risk groups in the adult population of Moscow, 2012–2016. Tuberculosis and Socially Significant Diseases. 2017;(2):10–15. (In Russ.) Available at: http://tb-journal.ru/wp-content/uploads/2022/08/002_tub0217.pdf.

5. Lapshina I.S., Tsybikova E.B., Kotlovskiy M.Yu. Groups at high risk of developing respiratory tuberculosis among adult population of Kaluga Oblast. Tuberculosis and Lung Diseases. 2022;100(11):20–28. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-11-20-28.

6. Zellweger J.P., Sotgiu G., Corradi M., Durando P. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB). Med Lav. 2020;111(3):170–183. https://doi.org/10.23749/mdl.v111i3.9983.

7. Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol. 2011:814943. https://doi.org/10.1155/2011/814943.

8. Andersen P., Doherty T.M., Pai M., Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med. 2007;13(5):175–182. https://doi.org/10.1016/j.molmed.2007.03.004.

9. Mack U., Migliori G.B., Sester M., Rieder H.L., Ehlers S., Goletti D. et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009;33(5):956–973. https://doi.org/10.1183/09031936.00120908.

10. Litvinov V.I., Slogotskaya L.V., Seltsovsky P.P., Shuster A.M., Martyanov V.A., Demin A.V. et al. A new skin test for the diagnosis of tuberculosis infection. Medical Journal of the Russian Federation. 2009;(1):52–56. (In Russ.) Available at: https://www.medlit.ru/j/rmj/rmj090152.htm.

11. Kiselev V.I., Baranovsky P.M., Rudykh I.V., Shuster A.M., Martyanov V.A., Mednikov B.L. et al. Clinical studies of a new skin test Diaskintest® for the diagnosis of tuberculosis. Tuberculosis and Lung Diseases. 2009;86(2):11–16. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=12195092.

12. Slogotskaya L.V., Litvinov V., Ovsyankina E., Seltsovsky P., Kudlay D. Results of QuantiFERON-TB Gold in-tube and skin testing with recombinant proteins CFP-10-ESAT-6 in children and adolescents with TB or latent TB infection. Paediatr Respir Rev. 2013;14(Suppl. 2):S65. https://doi.org/10.1016/S1526-0542(13)70092-7.

13. Shovkun L.A., Aksenova V.A., Kudlay D.A., Sarychev A.M. The role of immunological tests in the diagnosis of tuberculosis infection in children with juvenile idiopathic arthritis (JIA). Eur Respir J. 2018;52(Suppl. 62):PA2733. https://doi.org/10.1183/13993003.congress-2018.PA2733.

14. Kudlay D.A., Starshinova A.A., Dovgalyuk I.F. Recombinant tuberculosis allergen: 10 years of experience with the test in children and adolescents in the Russian Federation (meta-analysis data). Pediatriya – Zhurnal im G.N. Speranskogo. 2020;99(3):121–129. (In Russ.) https://doi.org/10.24110/0031-403X-2020-99-3-121-129.

15. Slogotskaya L.V., Bogorodskaya E.M. Comparative description of immunological tests for tuberculous infection detection. Mass screening opportunities. Tuberculosis and Lung Diseases. 2016;94(5):5–16. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-5-5-16.

16. Starshinova A., Zhuravlev V., Dovgaluk I., Panteleev A., Manina V., Zinchenko U. et al. A comparison of intradermal test with recombinant tuberculosis allergen (diaskintest) with other immunologic tests in the diagnosis of tuberculosis infection. Int J Mycobacteriol. 2018;7(1):32–39. https://doi.org/10.4103/ijmy.ijmy_17_18.

17. Diel R., Loddenkemper R., Niemann S., Meywald-Walter K., Nienhaus A. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med. 2011;183(1):88–95. https://doi.org/10.1164/rccm.201006-0974OC.

18. Rangaka M.X., Wilkinson K.A., Glynn J.R., Ling D., Menzies D., Mwansa-Kambafwile J. et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):45–55. https://doi.org/10.1016/S1473-3099(11)70210-9.

19. Bagisheva N.V., Mordyk A.V., Rudenko S.A., Neganova Yu.A., Neganova N.A. Comparative aspects of the course of newly diagnosed tuberculosis, isolated and in combination with COPD, in patients older than 50 years. Transbaikal Medical Bulletin. 2015;(3):73–77. (In Russ.) Available at: http://zabmedvestnik.ru/arhiv-nomerov/nomer-3-za-2015-god/sravnitelnye-aspekty-techenija-vpervye-vyjavlennogo-tuberkuleza-izolirovannogo-i-pri-ego-sochetanii-s-hobl-u-pacientov-starshe-50-let/506/12.pdf.

20. Bagisheva N.V., Mordyk A.V., Ivanova O.G., Batishcheva T.L. Tuberculosis and COPD: problems of comorbidity. Medical News of North Caucasus. 2014;9(4):329–331. (In Russ.) Available at: https://ssmj.ru/system/files/2014_02_289-293.pdf.

21. Lee C.H., Lee M.C., Shu C.C., Lim C.S., Wang J.Y., Lee L.N., Chao K.M. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis. 2013;13:194. https://doi.org/10.1186/1471-2334-13-194.

22. Dubrovskaya I.I., Bagisheva N.V., Mordyk A.V., Nebesnaya E.Yu., Bakhshieva L.I. Detection and differential diagnosis of tuberculosis in patients of the pulmonary department with community-acquired pneumonia and chronic obstructive pulmonary disease. Pulmonologiya. 2020;30(3):305–311. (In Russ.) https://doi.org/10.18093/0869-0189-2020-30-3-305-311.

23. Byrne A.L., Marais B.J., Mitnick C.D., Lecca L., Marks G.B. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015;32:138–146. https://doi.org/10.1016/j.ijid.2014.12.016.

24. Bogorodskaya E.M., Mazus A.I., Sinitsyn M.V., Krasnova S.V., Golokhvastova E.L., Belilovsky E.M. et al. Epidemiological effectiveness of the organization of prevention and early detection of tuberculosis among patients with HIV infection. Tuberculosis and Socially Significant Diseases. 2018;(2):4–15. (In Russ.) Available at: http://tb-journal.ru/wp-content/uploads/2022/08/001_tub218.pdf.

25. Sinitsyn M.V., Bogorodskaya E.M., Ayusheeva L.B., Belilovsky E.M. Latent tuberculosis infection among HIV-infected persons in the city of Moscow. Tuberculosis and Socially Significant Diseases. 2017;(2):42–49. (In Russ.) Available at: http://tb-journal.ru/wp-content/uploads/2022/08/007_tub0217.pdf.

26. Borodulina E.A., Kudlay D.A., Kuznetsova A.N., Gladunova E.P., Kalashnikova E.V. The use of the ELISPOT technological platform in the diagnosis of tuberculosis infection in patients with HIV infection. Immunologiya. 2021;42(4):395–402. (In Russ.) https://doi.org/10.33029/0206-4952-2021-42-4-395-402.

27. Ma Y., Xu Y., Cao X., Chen X., Zhong Y. Diagnostic value of interferon-γ release assay in HIV-infected individuals complicated with active tuberculosis: a systematic review and meta-analysis. Epidemiol Infect. 2021;149:e204. https://doi.org/10.1017/S0950268821001953.

28. Pettit A.C., Stout J.E., Belknap R., Benson C.A., Séraphin M.N., Lauzardo M. et al. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2021;73(7):e2278–e2284. https://doi.org/10.1093/cid/ciaa1135.

29. Kuday D.A. Biomarkers and immunological tests. Experimental and clinical parallels of latent tuberculosis infection. Tuberculosis and Lung Diseases. 2020;98(8):63–74. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-8-63-74.

30. Borisov S.E., Lukina G.V., Slogotskaya L.V., Kochetkov Ya.A., Guntupova L.D., Kulikovskaya N.V. Screening and monitoring of tuberculosis infection in rheumatological patients receiving genetically engineered biological preparations. Tuberculosis and Lung Diseases. 2011;88(6):42–50. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=16860556

31. Belokonova L.V., Kolomiets V.M., Devyanin P.A. Risk factors for the development of tuberculosis during the formation of an epidemic situation in penitentiary institutions. Vestnik Sovremennoi Klinicheskoi Mediciny. 2018;11(6):7–10. (In Russ.) https://doi.org/10.20969/VSKM.2018.11(6).7-10.

32. Shurygin A.A., Perminovа I.V., Kovtun A.A., Plotnikov V.P., Novikovа E.G., Kudlаy D.A. Tuberculous recombinant allergen as a part of preventive examination for tuberculosis among patients of 24-hour social service institutions. Tuberculosis and Lung Diseases. 2019;97(7):42–47. (In Russ.) https://doi.org/10.21292/2075-1230-2019-97-7-42-47.


Review

For citations:


Morozova TI, Doktorova NP. Latent tuberculosis infection in risk groups of the adult population of the Saratov Region. Meditsinskiy sovet = Medical Council. 2023;(4):92-100. (In Russ.) https://doi.org/10.21518/ms2023-054

Views: 415


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)